Younger Breast Cancer Survivors with Genetic Variants or In Situ Tumors Face Higher Risk of Second Primary Breast Cancer
Younger breast cancer survivors with germline pathogenic variants or an initial diagnosis of in situ disease have a significantly higher risk of developing a second primary breast cancer.